ACE2 and COVID-19: In conclusion, the results of the present study demonstrate that increased levels of oxidative stress markers, decreased levels of antioxidant indicators, and lower ACE2 expression levels are correlated with the disease severity and poor outcomes in hospitalized patients with COVID-19.